A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapy.
Subramanian A, Zhang M, Sharifi M, Moreno-Rodriguez T, Feng E, Rydzewski NR, Shrestha R, Zhu X, Zhao SG, Aggarwal R, Small EJ, Ding CC, Quigley DA, Sjöström M.
Subramanian A, et al. Among authors: zhao sg.
bioRxiv [Preprint]. 2024 Jun 3:2024.06.02.595931. doi: 10.1101/2024.06.02.595931.
bioRxiv. 2024.
PMID: 38895460
Free PMC article.
Preprint.